Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 2156OTHER 1356NIH 256NETWORK 62OTHER_GOV 26UNKNOWN 3INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14Lymphoid 5Breast 4Tumor-Agnostic 3Thoracic 3Gynecologic 3Sarcoma 2Plasma cell 2Other hematologic neoplasm 2CNS 2Other solid neoplasm 1Other 1Head & Neck 1Genitourinary 1Dermatologic 1Classical hematology 1

Conditions

Advanced Solid Cancer 1

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × Other solid neoplasm × Clear all
NCT07123415 2025-11-19

A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Aptabio Therapeutics, Inc.

Phase 1 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡